Healthcare -
Biotechnology - NASDAQ - US
$ 5.89
0.684 %
$ 252 M
Market Cap
-10.52
P/E
DMAC - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities DMAC - DiaMedica Therapeutics Inc.
36.8 M
LAST VALUE
3399.31%
2 YEAR CAGR
11.67%
5 YEAR CAGR
19.96%
10 YEAR CAGR